ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced ...

ICON plc, a clinical research organization, expanded its portfolio of artificial intelligence (AI) tools that aim to deliver efficiencies across the clinical trial process, including study startup, ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial intelligence (AI ...

Regarding infrastructure, Weil pointed to OpenAI’s $500 billion Stargate initiative, which is aimed at expanding U.S. energy ...

ICON's 2025 revenue guidance is $8.05 billion–$8.65 billion, a 1% growth midpoint, versus consensus $8.5 billion. Adjusted EPS for 2025 is forecasted at $13.00–$15.00, flat compared to 2024 ...

The intersection of longevity science and decentralized finance (DeFi) represents an exciting frontier in Web3’s growing ...

Those who knew Bridgette Hempstead describe her as a warrior for Africa-American women diagnosed with breast cancer.

Explore findings from a clinical trial revealing how interruptive decision support systems enhance suicide risk assessments ...

The ICON group defined tears as a macroscopic (as opposed to ... With respect to this, the Groningen statement is consistent with previous Delphi studies and clinical guidelines which include ...

It’s the quarterly season again as the ASX market announcements page becomes increasingly flooded with news updates.